MENOGENIX, INC.
Small molecule therapeutic for menopause-related hot flashes and vasomotor symptoms
- Sector
- Biotech
- Headquarters
- Aurora, CO
- Founded
- 2010
- Latest Form D
- $75K, Dec 2017
- Total capital
- $2.6M
- Federal grants
- $1.4M
- 3 awards · 2018–2020
- Rank in peer group#215 of 326
- Private capital raised
- $1.2M
- 4 Form D · last Dec 2017
- 106 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 1 pending
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · Expanded Clinical Trial of Granulocyte Colony-Stimulating Factor (G-CSF) to Treat Hot Flush and Other Vasomotor Symptoms in Women with Naturally-Occurring and Surgically-Induced Menopause$300K
- Federal grantHealth and Human S · Phase I · Effect of Repeated Administration of G-CSF on Hot Flashes and Other Vasomotor Symptoms of Menopause$195K
- Federal grantHealth and Human S · Phase I · Effect of Repeated Administration of G-CSF on Hot Flashes and Other Vasomotor Symptoms of Menopause$888K
- Private capital raisedForm D · SEC · 4th filing$75K
- Private capital raisedForm D · SEC · 3rd filing$200K
- Private capital raisedForm D · SEC · 2nd filing$405K
- Private capital raisedForm D · SEC · 1st filing$500K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 326 peers
Line = medianBiotech · Molecule
- Federal grantsBelow median
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- James Woodruff EmlenResearcherDirectorLinked by $300K in grants as PI
- Richard C. DukeResearcherDirectorLinked by $1.1M in grants as PI
- Debra M. DukeExecutive OfficerNamed in SEC Form D filings
- T. Richard FortDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 1- PendingCompositions And Methods For Threating Symptoms Associated With Menopause, Hormonal Variations And ArthritisUSPTOApplication PCTUS2009051429
Related companies, and why
- DiaMedica Therapeutics Inc.Similar federal contract value in Biotech · null in contracts
- DURAVAX INCSimilar federal contract value in Biotech · null in contracts
- NEW HORIZON BIOTECH INCSimilar federal contract value in Biotech · null in contracts
- Sana BiotechnologySimilar federal contract value in Biotech · null in contracts
- Walden BiosciencesSimilar federal contract value in Biotech · null in contracts
- Kriya TherapeuticsSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .